Editorial Commentary
Is robot-assisted partial nephrectomy safe for high complexity tumors?
Translational Andrology and Urology
2020;
9
(6)
:2455-2458
.
(27 December 2020)
Growing evidence for benefits of minimally invasive radical cystectomy
Translational Andrology and Urology
2020;
9
(6)
:2459-2461
.
(27 December 2020)
Current clues for better analgesic prescription after urologic surgery
Translational Andrology and Urology
2020;
9
(6)
:2462-2466
.
(27 December 2020)
Vesical imaging reporting and data system (VI-RADS) and impact on identifying depth of invasion with subsequent management in bladder cancer patients: ready for prime time?
Translational Andrology and Urology
2020;
9
(6)
:2467-2470
.
(27 December 2020)
Open versus minimal invasive radical cystectomy
Translational Andrology and Urology
2020;
9
(6)
:2471-2473
.
(27 December 2020)
Robot-assisted partial nephrectomy is safe and effective for complex renal masses when performed by experienced surgeons
Translational Andrology and Urology
2020;
9
(6)
:2474-2478
.
(27 December 2020)
Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?
Translational Andrology and Urology
2020;
9
(6)
:2479-2482
.
(27 December 2020)
Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer
Translational Andrology and Urology
2020;
9
(6)
:2483-2487
.
(27 December 2020)
Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?
Translational Andrology and Urology
2020;
9
(6)
:2488-2492
.
(27 December 2020)
Original Article
Efficacy and feasibility of day surgery using transurethral seminal vesiculoscopy under caudal block anesthesia for intractable hemospermia
Translational Andrology and Urology
2020;
9
(6)
:2493-2499
.
(27 December 2020)
Analysis of cardiovascular risks for erectile dysfunction in Chinese patients with type 2 diabetes mellitus lacking clinical symptoms of cardiovascular diseases
Translational Andrology and Urology
2020;
9
(6)
:2500-2509
.
(27 December 2020)
Systematic sampling during MRI-US fusion prostate biopsy can overcome errors of targeting—prospective single center experience after 300 cases in first biopsy setting
Translational Andrology and Urology
2020;
9
(6)
:2510-2518
.
(27 December 2020)
Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis
Translational Andrology and Urology
2020;
9
(6)
:2519-2532
.
(27 December 2020)
Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation therapy
Translational Andrology and Urology
2020;
9
(6)
:2533-2540
.
(27 December 2020)
Comparison of postoperative complications of ileal conduits versus orthotopic neobladders
Translational Andrology and Urology
2020;
9
(6)
:2541-2554
.
(27 December 2020)
Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma
Translational Andrology and Urology
2020;
9
(6)
:2555-2571
.
(27 December 2020)
A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients
Translational Andrology and Urology
2020;
9
(6)
:2572-2586
.
(27 December 2020)
Adding radiotherapy based on chemotherapy can improve cancer-specific survival in N3 penile cancer: a SEER-based study
Translational Andrology and Urology
2020;
9
(6)
:2587-2595
.
(27 December 2020)
The value of magnetic resonance imaging geometric parameters in pre-assessing the surgical approaches of pelvic fracture urethral injury
Translational Andrology and Urology
2020;
9
(6)
:2596-2605
.
(27 December 2020)
Robot-assisted radical cystectomy with totally intracorporeal neobladder diversion: perioperative, oncologic, and functional outcomes
Translational Andrology and Urology
2020;
9
(6)
:2606-2615
.
(27 December 2020)
Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer
Translational Andrology and Urology
2020;
9
(6)
:2616-2628
.
(27 December 2020)
Development and internal validation of nomograms for the prediction of postoperative survival of patients with grade 4 renal cell carcinoma (RCC)
Translational Andrology and Urology
2020;
9
(6)
:2629-2639
.
(27 December 2020)
C3, C3AR1, HLA-DRA, and HLA-E as potential prognostic biomarkers for renal clear cell carcinoma
Translational Andrology and Urology
2020;
9
(6)
:2640-2656
.
(27 December 2020)
Expression and clinical significance of interleukin-9 in renal tumors
Translational Andrology and Urology
2020;
9
(6)
:2657-2664
.
(27 December 2020)
Validation of the World Health Organization/International Society of Urological Pathology grading for Chinese patients with clear cell renal cell carcinoma
Translational Andrology and Urology
2020;
9
(6)
:2665-2674
.
(27 December 2020)
Bioinformatic gene analysis for possible biomarkers and therapeutic targets of hypertension-related renal cell carcinoma
Translational Andrology and Urology
2020;
9
(6)
:2675-2687
.
(27 December 2020)
Counter incision is a safe and effective method for alternative reservoir placement during inflatable penile prosthesis surgery
Translational Andrology and Urology
2020;
9
(6)
:2688-2696
.
(27 December 2020)
Utilization of a three-dimensional printed kidney model for favorable TRIFECTA achievement in early experience of robot-assisted partial nephrectomy
Translational Andrology and Urology
2020;
9
(6)
:2697-2704
.
(27 December 2020)
Resection of adult polycystic kidney with retroperitoneal laparoscopic technique assisted by arterial embolization
Translational Andrology and Urology
2020;
9
(6)
:2705-2712
.
(27 December 2020)
Effect of obesity on the prognosis and recurrence of prostate cancer after radical prostatectomy: a meta-analysis
Translational Andrology and Urology
2020;
9
(6)
:2713-2722
.
(27 December 2020)
Is a ureteral stent required before flexible ureteroscopy?
Translational Andrology and Urology
2020;
9
(6)
:2723-2729
.
(27 December 2020)
The influence of processed total non-forward and non-motile sperm count on the outcome of artificial insemination with the husband’s semen
Translational Andrology and Urology
2020;
9
(6)
:2730-2736
.
(27 December 2020)
Comprehensive analysis of glutathione peroxidase-1 (GPX1) expression and prognostic value in three different types of renal cell carcinoma
Translational Andrology and Urology
2020;
9
(6)
:2737-2750
.
(27 December 2020)
Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma
Translational Andrology and Urology
2020;
9
(6)
:2751-2763
.
(27 December 2020)
Technical Note
Percutaneous nephrostomic decortication: a microinvasive surgery for posterior renal cyst
Translational Andrology and Urology
2020;
9
(6)
:2764-2770
.
(27 December 2020)
Review Article
Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model
Translational Andrology and Urology
2020;
9
(6)
:2771-2785
.
(27 December 2020)
Diagnosis of hypogonadism in patients treated with low energy shock wave therapy for erectile dysfunction: a narrative review
Translational Andrology and Urology
2020;
9
(6)
:2786-2796
.
(27 December 2020)
Impact of environmental toxin exposure on male fertility potential
Translational Andrology and Urology
2020;
9
(6)
:2797-2813
.
(27 December 2020)
Glans penis augmentation using hyaluronic acid for the treatment of premature ejaculation: a narrative review
Translational Andrology and Urology
2020;
9
(6)
:2814-2820
.
(27 December 2020)
The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review
Translational Andrology and Urology
2020;
9
(6)
:2821-2830
.
(27 December 2020)
Case Report
Prostate biopsy free system for laparoscopic radical prostatectomy in a pituitary dwarfism: a case report
Translational Andrology and Urology
2020;
9
(6)
:2831-2835
.
(27 December 2020)
Mixed granulosa-Sertoli sex cord-stromal tumor of the testis: clinical, ultrasonic and histopathological features: a case report
Translational Andrology and Urology
2020;
9
(6)
:2836-2841
.
(27 December 2020)
Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report
Translational Andrology and Urology
2020;
9
(6)
:2842-2847
.
(27 December 2020)
Novel mutations in response to vitamin B6 in primary hyperoxaluria type 1 after only kidney transplantation: a case report
Translational Andrology and Urology
2020;
9
(6)
:2848-2854
.
(27 December 2020)
Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review
Translational Andrology and Urology
2020;
9
(6)
:2855-2861
.
(27 December 2020)
Letter to the Editor
Technical caveats in salvage robot assisted radical prostatectomy
Translational Andrology and Urology
2020;
9
(6)
:2862-2863
.
(27 December 2020)
Editorial on Muscle-invasive Bladder Cancer1
Where are we now and where are we heading in muscle invasive bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2864-2865
.
(27 December 2020)
Review Article on Muscle-invasive Bladder Cancer1
Tumor heterogeneity in muscle-invasive bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2866-2880
.
(27 December 2020)
Update on bladder cancer molecular subtypes
Translational Andrology and Urology
2020;
9
(6)
:2881-2889
.
(27 December 2020)
Role of magnetic resonance imaging in tumor staging and follow-up for bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2890-2907
.
(27 December 2020)
Role of PET/CT in muscle-invasive bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2908-2919
.
(27 December 2020)
Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2920-2937
.
(27 December 2020)
Partial cystectomy for muscle-invasive bladder cancer: a review of the literature
Translational Andrology and Urology
2020;
9
(6)
:2938-2945
.
(27 December 2020)
Review of the evidence for robotic-assisted robotic cystectomy and intra-corporeal urinary diversion in bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2946-2955
.
(27 December 2020)
Is there an oncological benefit to extended lymphadenectomy for muscle-invasive bladder cancer?
Translational Andrology and Urology
2020;
9
(6)
:2956-2964
.
(27 December 2020)
The optimal management of variant histology in muscle invasive bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2965-2975
.
(27 December 2020)
Perioperative immunotherapy for muscle-invasive bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2976-2985
.
(27 December 2020)
Enhanced recovery after surgery of patients undergoing radical cystectomy for bladder cancer
Translational Andrology and Urology
2020;
9
(6)
:2986-2996
.
(27 December 2020)
Health-related quality of life after radical cystectomy
Translational Andrology and Urology
2020;
9
(6)
:2997-3006
.
(27 December 2020)
Editorial on Surgery for Urologic Cancers2
Surgery for urological cancers
Translational Andrology and Urology
2020;
9
(6)
:3007-3008
.
(27 December 2020)
Review Article on Surgery for Urologic Cancers2
Transperineal prostate biopsy: a review of technique
Translational Andrology and Urology
2020;
9
(6)
:3009-3017
.
(27 December 2020)
Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis?
Translational Andrology and Urology
2020;
9
(6)
:3018-3024
.
(27 December 2020)
Open retropubic radical prostatectomy
Translational Andrology and Urology
2020;
9
(6)
:3025-3035
.
(27 December 2020)
Surgical techniques to improve continence recovery after robot-assisted radical prostatectomy
Translational Andrology and Urology
2020;
9
(6)
:3036-3048
.
(27 December 2020)
A narrative review of pelvic lymph node dissection in prostate cancer
Translational Andrology and Urology
2020;
9
(6)
:3049-3055
.
(27 December 2020)
Transurethral resection of bladder tumour (TURBT)
Translational Andrology and Urology
2020;
9
(6)
:3056-3072
.
(27 December 2020)
Radical cystectomy: a review of techniques, developments and controversies
Translational Andrology and Urology
2020;
9
(6)
:3073-3081
.
(27 December 2020)
The evolving role of lymphadenectomy for bladder cancer: why, when, and how
Translational Andrology and Urology
2020;
9
(6)
:3082-3093
.
(27 December 2020)
Radical inguinal orchidectomy: the gold standard for initial management of testicular cancer
Translational Andrology and Urology
2020;
9
(6)
:3094-3102
.
(27 December 2020)
Retroperitoneal lymph node dissection for germ cell tumour
Translational Andrology and Urology
2020;
9
(6)
:3103-3111
.
(27 December 2020)
Minimally invasive radical nephrectomy: a contemporary review
Translational Andrology and Urology
2020;
9
(6)
:3112-3122
.
(27 December 2020)
The role of open radical nephrectomy in contemporary management of renal cell carcinoma
Translational Andrology and Urology
2020;
9
(6)
:3123-3139
.
(27 December 2020)
Role of minimally invasive partial nephrectomy in the management of renal mass
Translational Andrology and Urology
2020;
9
(6)
:3140-3148
.
(27 December 2020)
Open partial nephrectomy: current review
Translational Andrology and Urology
2020;
9
(6)
:3149-3159
.
(27 December 2020)
Nephron-sparing surgery for the management of upper tract urothelial carcinoma: an outline of surgical technique and review of outcomes
Translational Andrology and Urology
2020;
9
(6)
:3160-3167
.
(27 December 2020)
The nephroureterectomy: a review of technique and current controversies
Translational Andrology and Urology
2020;
9
(6)
:3168-3190
.
(27 December 2020)
The role of penectomy in penile cancer—evolving paradigms
Translational Andrology and Urology
2020;
9
(6)
:3191-3194
.
(27 December 2020)
Penile sparing therapy for penile cancer
Translational Andrology and Urology
2020;
9
(6)
:3195-3209
.
(27 December 2020)
Inguinal lymph node dissection for penile cancer: a contemporary review
Translational Andrology and Urology
2020;
9
(6)
:3210-3218
.
(27 December 2020)
Disclosure:
1. The series “Muscle-invasive Bladder Cancer” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Ja Hyeon Ku, Ho Kyung Seo and Seok Ho Kang served as the unpaid Guest Editors for the series.2. The series “Surgery for Urologic Cancers” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Shomik Sengupta served as the unpaid Guest Editor for the series.
